These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 36569912)

  • 61. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
    Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
    J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanism of experimental autoimmune neuritis in Lewis rats: the dual role of macrophages.
    Shin T; Ahn M; Matsumoto Y; Moon C
    Histol Histopathol; 2013 Jun; 28(6):679-84. PubMed ID: 23440744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline.
    Zhang ZY; Zhang Z; Fauser U; Schluesener HJ
    J Cell Mol Med; 2009 Feb; 13(2):341-51. PubMed ID: 18400050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased Levels of IL-34 in Acquired Immune-Mediated Neuropathies.
    Rezaei S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
    J Mol Neurosci; 2021 Jan; 71(1):137-141. PubMed ID: 32588399
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in Thyroid Function and Autoantibodies in the Development of Guillain-Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Tu Y; Gong X; Zeng G; Zhuo W; Li Z; Yu X
    Front Neurol; 2020; 11():1018. PubMed ID: 33013669
    [No Abstract]   [Full Text] [Related]  

  • 66. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
    Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Yuki N; Tagawa Y; Handa S
    J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.
    Schmidt B; Toyka KV; Kiefer R; Full J; Hartung HP; Pollard J
    Muscle Nerve; 1996 Apr; 19(4):474-87. PubMed ID: 8622727
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ben-Smith A; Gaston JS; Barber PC; Winer JB
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):362-8. PubMed ID: 8890774
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
    Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
    Ueda M; Kusunoki S
    Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology.
    Pollard JD; Armati PJ
    J Peripher Nerv Syst; 2011 Mar; 16(1):15-23. PubMed ID: 21504498
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Autoantibodies in immune-mediated inflammatory neuropathies.
    Martín-Aguilar L; Pascual-Goñi E; Querol L
    Med Clin (Barc); 2019 Nov; 153(9):360-367. PubMed ID: 31443948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
    Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
    Front Immunol; 2019; 10():515. PubMed ID: 30984164
    [No Abstract]   [Full Text] [Related]  

  • 75. Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis.
    Vriesendorp FJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S164-8. PubMed ID: 9396704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inflammatory neuropathies.
    Hughes RA
    Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system.
    Kurz M; Pischel H; Hartung HP; Kieseier BC
    J Peripher Nerv Syst; 2005 Sep; 10(3):311-8. PubMed ID: 16221290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
    Xia RH; Yosef N; Ubogu EE
    J Neuroimmunol; 2010 Feb; 219(1-2):54-63. PubMed ID: 20034679
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy.
    Chaudhary UJ; Rajabally YA
    J Neurol; 2021 Apr; 268(4):1366-1373. PubMed ID: 33170339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.